Guess stock rises after retailer posts narrower quarterly loss
Shares of Guess Inc. (GES) rose more than 5% in the aftermarket Wednesday after the retailer reported a narrower-than-expected adjusted fiscal first-quarter loss and sales that were above Wall Street expectations. Guess lost $11.8 million, or 22 cents a share, in the quarter, swinging from earnings of $8 million, or 12 cents a share, in the year-ago quarter. Adjusted for one-time items, Guess lost 7 cents a share. Revenue dropped 4% to $570 million. Analysts polled by FactSet expected Guess to report an adjusted loss of 28 cents a share on sales of $556 million. Guess also raised its dividend to 30 cents a share, from 22.5 cents a share. The retailer guided for a fiscal 2024 revenue increase between 2% and 4%, and adjusted EPS between $2.60 and $2.90. Guess shares ended the regular trading day down 0.8%.
-Claudia Assis
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-24-23 1643ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Amazon Earnings: AWS Growth Accelerates and Profit Margins Improve
-
SiriusXM Earnings: Decent Results With Plan for Technology and Content Investment to Drive Growth
-
Coca-Cola Earnings: Solid Volume On Innovation and Digital Engagement
-
Is Berkshire Hathaway a Buy Before the Annual Meeting?
-
Investment Opportunities in the Drug Distribution Industry
-
Why the End of Quantitative Tightening Matters
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins
-
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?